AI assistant
StageZero Life Sciences Ltd. — Regulatory Filings 2020
Jun 23, 2020
44586_rns_2020-06-22_800d0704-79c9-4a72-8719-aede030fcda4.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
UNDERTAKING
Section 4.2(a)(x)(x.1) of National Instrument 44-101
-
TO: Ontario Securities Commission British Columbia Securities Commission Alberta Securities Commission (collectively, the " Securities Administrators ")
-
RE: StageZero Life Sciences Ltd. Final Short Form Prospectus dated June 22, 2020 (the “ Prospectus ”)
StageZero Life Sciences Ltd. (the " Corporation ") hereby undertakes to the Securities Administrators that it will file promptly any documents and materials required to be filed but that have not been executed at the time of filing final materials, including the Agency Agreement and Warrant Indenture, and in any event no later than seven days after the document becomes effective.
Capitalized terms not defined herein have the meanings ascribed to them in the Prospectus of the Corporation.
Dated this 22[nd] day of June 2020.
STAGEZERO LIFE SCIENCES LTD.
"James Howard-Tripp"
Per: _________________________________ James Howard-Tripp Chairman and Chief Executive Officer
14852643.4